Author:
Pedotti Rosetta,Muros-Le Rouzic Erwan,Raposo Catarina,Schippling Sven,Jessop Nikki
Subject
Neurology (clinical),Neurology,General Medicine
Reference29 articles.
1. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021
2. Apostolidis, S.A., Kakara, M., Painter, M.P., Goel, R.R., Mathew, D., Lenzi, K., Rezk, A., Patterson, K.R., Espinoza, D.A., Kadri, J.C., Markowitz, D.M., Markowitz, C., Mexhitaj, P., Jacobs, D., Babb, A., Betts, M.R., Luning Prak, E.T., Weiskopf, D., Grifoni, A., Lundgreen, K.A., Gouma, S., Sette, A., Bates, P., Hensley, S.E., Greenplate, A.R., Wherry, E.J., Li, R., Bar-Or, A., 2021. Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy. medRxiv 2021.06.23.21259389; 10.1101/2021.06.23.21259389.
3. Asplund Högelin, K., Ruffin, N., Pin, E., Månberg, A., Hober, S., Gafvelin, G., Grönlund, H., Nilsson, P., Khademi, M., Olsson, T., Piehl, F., Al Nimer, F., 2021. Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. Available at SSRN: https://ssrn.com/abstract=3796531 or http://dx.doi.org/10.2139/ssrn.3796531.
4. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study;Bar-Or;Neurology,2020
5. Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study;Conte;Mult. Scler. Relat. Disord.,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献